Orgenesis (ORGS): Revenue Growth QoQ

Corporate company logo of Orgenesis Inc (ORGS)

Quarterly commercial revenue growth for Orgenesis Inc. demonstrates a fundamental sales trend, where 117.40 reflects the most recent metric value. The business is based on an asset-light IT consulting model within the cell therapy sector, ensuring high margins. Revenue is generated through the implementation of local drug manufacturing in major clinics. A decentralized ecosystem of mobile laboratories guarantees a steady influx of B2B clients under strict FDA oversight.

Orgenesis Inc (ORGS) - Quarterly Revenue Increase from 07/04/2022 to 10/26/2024

Financial and market metric breakdowns for Orgenesis (ORGS)

- stock price and consensus target price:
- stock exchange capitalization data:
Initial company analysis:orgenesis.com - ORGS
Mass-produced product of orgenesis.com

For investors in the cell therapy sector, Orgenesis Inc. is an attractive asset due to the increasing predictability of revenues driven by service contracts. When analyzing the quarterly revenue growth vector, one should evaluate the percentage change in current sales relative to the same period last year, which allows for the identification of the platform's expansion stability and confirms the long-term competitiveness of the company's capital.

Competitors of Orgenesis Inc.

VEEV: Quarterly Sales Growth|Quarterly Revenue Growth Rate Doximity|HQY: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Waystar Health (WAY)|Revenue Growth QoQ CorVel Healthcare|Quarterly Revenue Growth Privia Medical Group|Quarterly Sales Growth HURN (Huron Corp)|Quarterly Sales Growth Certara CERT|Quarterly Revenue Growth OMCL (Omnicell Inc)|Quarterly Sales Growth Rate GoodRx Inc (GDRX)|Schrodinger Corp - Quarterly Revenue Growth|Revenue Dynamics QoQ PHR|OMDA: Quarterly Revenue Growth|Evolent Health, Inc. - Quarterly Revenue Increase|Revenue Growth QoQ HealthStream Corp|DH: Quarterly Revenue Increase|Quarterly Sales Growth CCSI (Consensus)|Quarterly Sales Growth Rate Agilon Health|Quarterly Revenue Growth ABSI (Absci)|soyoung.com (SY) - Quarterly Revenue Growth Rate|NRC - Revenue Growth QoQ|Quarterly Sales Growth Rate Spok Holdings Inc SPOK|OPRX (OptimizeRx) - Quarterly Sales Growth|TBRG - Quarterly Sales Growth Rate|Quarterly Sales Growth SLP|Quarterly Revenue Growth Rate sophiagenetics.com SOPH|Quarterly Revenue Growth HCAT|CCLD (CareCloud Inc.) - Quarterly Revenue Increase|Revenue Growth QoQ Research Solutions Inc. RSSS|DLHC - Quarterly Sales Growth|ONMD - Revenue Growth QoQ|Quarterly Sales Growth Rate Scienture Holdings Inc SCNX|HCTI: Quarterly Revenue Growth|Sales Growth QoQ ISPC|BFRG (Bullfrog AI) - Quarterly Revenue Growth|Quarterly Sales Growth SCWorx Inc (WORX)|Quarterly Revenue Growth MSPR|ICCT - Quarterly Revenue Growth Rate|Quarterly Revenue Growth MEDS (TRxADE Health Corp)|RCM: Sales Growth QoQ|SHCR - Revenue Growth QoQ|Quarterly Sales Growth Rate Streamline Health Solutions STRM|SYRA (Syra Health Corp) - Quarterly Sales Growth|AMEH: Sales Change QoQ|Quarterly Sales Growth MODN|Quarterly Revenue Growth Rate NextGen NXGN